MN566 Advanced Nursing Midterm Exam 2026/2027 | Exam Questions with Verified Questions and Answers and Detailed Rationales | AGNP Advanced Practice Prep | Get HighScore | Instant Download

INSTANT PDF DOWNLOAD — This is the comprehensive exam preparation guide for the MN566 Advanced Nursing Midterm Exam for the 2026/2027 academic year, featuring verified questions and answers with detailed rationales including multiple-choice and clinical scenario question formats . Designed for Nurse Practitioner students enrolled in the MN566 course at Purdue University Global, this resource consolidates the critical advanced practice concepts required to achieve a top score on the midterm assessment . The guide is meticulously aligned with the current MN566 curriculum, covering essential topics including pharmacology, endocrinology, infectious diseases, otolaryngology, neurology, pulmonology, cardiology, and evidence-based clinical decision-making. This verified resource provides comprehensive coverage of key MN566 Advanced Nursing Midterm Exam topics, including: Pharmacology & Weight Management: Phentermine and Diethylpropion: Promote weight loss by decreasing appetite; they are central nervous system (CNS) stimulants that suppress appetite by increasing the availability of norepinephrine at receptors in the brain Maximum Recommended Duration: 3 months or less for non-amphetamines; these are Schedule IV drugs Monitoring Requirements: Baseline CMP (watch electrolytes and creatinine); screen for depression before prescribing Phentermine Adverse Effects: Increased HR and BP, dry mouth, constipation Topiramate Role in Weight Loss: Increases satiety; contraindicated in severe hepatic impairment and not approved in children Phentermine/Topiramate Administration: Given before 1600 to avoid insomnia; use with caution in patients with history of drug abuse, glaucoma, pregnancy, HTN, hyperthyroidism Phentermine/Topiramate Adverse Effects: Insomnia, nervousness, anxiety, depression, blurred vision Contraindications to Phentermine/Topiramate: Glaucoma and hyperthyroidism are contraindications Orlistat and Vitamin K: Monitor Coumadin as Vitamin K deficiency may occur and intensify effect of Coumadin Lorcaserin: Reduces waist circumference, fasting glucose, insulin, total cholesterol, LDL, triglycerides; contraindicated with CrCl 30 mL/min Naltrexone and Bupropion: Black box warning for increased risk of suicidal ideation in children, adolescents, and young adults; do not take within 2 weeks of taking an MAOI; reduces effects of opioids due to antagonist properties Liraglutide MOA: Promotes weight loss by slowing gastric emptying and increasing satiety; not unusual for baseline HR to increase 10-20 bpm; most weight loss occurs during first 6 months of treatment Weight Loss Stages: Stage 0 (BMI ≥25 = lifestyle therapy); Stage 1 (BMI 25-26 lifestyle, consider drug therapy; BMI ≥27 lifestyle + drug therapy); Stage 2 (BMI 27-34 lifestyle + drug therapy; BMI ≥35 lifestyle + drug therapy + consider bariatric surgery) Drug Metabolism & Interactions: CYP450 Inhibitors (decrease medication metabolism): Valproate, Isoniazid, Sulfonamide, Amiodarone, Chloramphenicol, Ketoconazole, Grapefruit juice, Quinidine, Cimetidine, Ciprofloxacin, Erythromycin, INH CYP450 Inducers (increase medication metabolism): Carbamazepine, Rifampin, Alcohol, Phenytoin, Griseofulvin, Phenobarbital Bactericidal Agents: Directly lethal to bacteria at clinically achievable concentrations; includes aminoglycosides, beta-lactams, fluoroquinolones, metronidazole, most antimycobacterial agents, streptogramins, vancomycin Bacteriostatic Agents: Slow bacterial growth but do not cause cell death; includes clindamycin, macrolides, sulfonamides, tetracyclines Most Important Patient Education: It is imperative that antibiotics not be discontinued prematurely Four Mechanisms of Microbial Drug Resistance: 1) decrease drug concentration at action site, 2) alter structure of drug target molecules, 3) produce a drug antagonist, 4) cause drug inactivation Pregnancy & Antibiotics: Fluoroquinolones in Pregnancy: Not safe (Category C); problems with tendons, joints, large vessels; avoid due to potential cartilage damage risk Tetracyclines in Pregnancy: Teratogenic; avoided entirely (Category X); causes weakening, hypoplasia, and discoloration of long bones and teeth Aminoglycosides in Pregnancy: Not safe (Category C/D); ototoxicity, nephrotoxicity; Gentamicin can cause irreversible hearing loss in infants Macrolides in Pregnancy: Safe (Category B); alternative for penicillins; may cause arrhythmia (prolong QT interval) Cephalosporins in Pregnancy: Safe (Category B); beta-lactam antibiotics (1-3 generations) Streptomycin and Kanamycin: Avoided entirely in pregnancy (Category X); may cause hearing loss Breastfeeding: As a general guideline, antibiotics and all other drugs should be avoided by women who are breastfeeding; Amoxicillin is safe Infectious Diseases: Most Common Cause of CAP: Streptococcus pneumoniae Long-Acting Beta Agonist for Asthma: Patient should also be taking an inhaled corticosteroid TB Drugs Prophylactic Administration: Take on an empty stomach to facilitate absorption Stages of Change - Preparation Stage: Patient has decided to quit, has bought nicotine gum, and is interested in cessation medications Horner's Syndrome: New-onset ptosis, miosis, and anhidrosis (lack of sweating) in a patient with history of lung cancer Secondary Syphilis Oral Lesions: Nonvesicular, symmetrical, scattered on oropharynx and mouth Mononucleosis with Strep Co-infection: Amoxicillin given to patient with EBV can cause diffuse maculopapular rash; presents with fever increase (not decrease), lymphadenopathy (posterior and anterior cervical), hepatosplenomegaly, and rash Otolaryngology (ENT) Disorders: Rinne Test: Compares air conduction (AC) to bone conduction (BC); tuning fork placed on mastoid process, then near ear canal; distinguishes from Weber test which compares lateralization of sound Sensorineural Hearing Loss: Lesion in organ of Corti or central neural pathways including CN VIII and auditory cortex; presbycusis is age-related sensorineural loss Conductive Hearing Loss: Impaired passage of sound waves through tympanic membrane and middle ear ossicles (malleus, incus, stapes); often reversible Causes of Sensorineural Loss: Presbycusis, Meniere's disease, acoustic neuroma, aminoglycosides, aspirin, quinine, trauma, syphilis, mumps Causes of Conductive Loss: Cerumen impaction, TM perforation, chronic ear infections, otosclerosis, congenital abnormalities Acoustic Neuroma: Unilateral sensorineural hearing loss with headache; benign tumor of vestibulocochlear nerve (CN VIII) Presbycusis: Age-related sensorineural hearing loss; bilateral and progressive; affects high frequencies Otitis Externa (Swimmer's Ear): Inflammation of membranous lining of auditory canal; classic sign = tenderness on traction of pinna AND/OR pain on pressure over tragus Fungal Otitis Externa (Otomycosis) : Black, malodorous discharge; most commonly due to Aspergillus niger or Candida Otitis Externa Patient Education: Avoid water in ears for 4-6 weeks after symptoms subside [citation